since the method of lipid lowering is different from the currently available treatments. This article describes the currently available data for the knockdown of ApoB by antisense oligonucleotides ...
[48] Several lipid-lowering studies have demonstrated that a large proportion of patients who achieve their LDL-C or non-HDL-C goals remain above the treatment target for apoB, which represents an ...